Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry.

[1]  G. Ayele,et al.  Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves). , 2015, JACC. Cardiovascular interventions.

[2]  M. Mack,et al.  Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy , 2015, Circulation.

[3]  P. Pibarot,et al.  Myocardial Injury After Transaortic Versus Transapical Transcatheter Aortic Valve Replacement. , 2015, The Annals of thoracic surgery.

[4]  P. Pibarot,et al.  Myocardial injury following transcatheter aortic valve implantation: insights from delayed-enhancement cardiovascular magnetic resonance. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  M. Mack,et al.  Propensity-Matched Comparisons of Clinical Outcomes after Transapical or Transfemoral TAVR: A PARTNER-I Trial Substudy , 2015 .

[6]  P. Lemos,et al.  Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. , 2015, Journal of the American College of Cardiology.

[7]  A. Jaffe,et al.  Defining the Optimal Cardiac Troponin T Threshold for Predicting Death Caused by Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention , 2014, Circulation. Cardiovascular interventions.

[8]  H. Figulla,et al.  Impact of rapid ventricular pacing during TAVI on microvascular tissue perfusion , 2014, Clinical Research in Cardiology.

[9]  J. Mehilli,et al.  Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. , 2014, JAMA.

[10]  J. Mega,et al.  Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. , 2013, Journal of the American College of Cardiology.

[11]  M. Mack,et al.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). , 2013, Journal of the American College of Cardiology.

[12]  P. Teirstein,et al.  Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). , 2013, Journal of the American College of Cardiology.

[13]  J. Lemos.  Increasingly Sensitive Assays for Cardiac Troponins: A Review , 2013 .

[14]  G. Parodi,et al.  Prognostic value of myocardial injury following transcatheter aortic valve implantation. , 2013, The American journal of cardiology.

[15]  I. Barbash,et al.  Prevalence and effect of myocardial injury after transcatheter aortic valve replacement. , 2013, The American journal of cardiology.

[16]  I. Barbash,et al.  Impact of transapical aortic valve replacement on apical wall motion. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  S. Windecker,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[18]  Jeroen J. Bax,et al.  Third universal definition of myocardial infarction. , 2012, European heart journal.

[19]  B. Bouma,et al.  Predictors and Prognostic Value of Myocardial Injury During Transcatheter Aortic Valve Implantation , 2012, Circulation. Cardiovascular interventions.

[20]  P. Leprince,et al.  Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.

[21]  P. Pibarot,et al.  Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. , 2011, Journal of the American College of Cardiology.

[22]  H. Baumgartner,et al.  Comparison Between Transcatheter and Surgical Prosthetic Valve Implantation in Patients With Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction , 2010, Circulation.

[23]  J. Nordrehaug,et al.  Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms. , 2010, The American journal of cardiology.

[24]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[25]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  E. Topol,et al.  Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. , 2002, Journal of the American College of Cardiology.

[27]  S. Kathiresan,et al.  A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. , 2002, Journal of the American College of Cardiology.

[28]  Josep Rodés-Cabau,et al.  Transcatheter aortic valve implantation: current and future approaches , 2012, Nature Reviews Cardiology.

[29]  S. Windecker,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, European heart journal.

[30]  M. Panteghini.  A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins , 2009, Clinical chemistry and laboratory medicine.